Influence of pharmacist intervention on prescribing of angiotensin- converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients

American Journal of Health-System Pharmacy

Volumn 67, Issue 4, 2010, Pages 290-294

  LaMarr, Brandon ^a   Valdez, Connie ^b   Driscoll, Katie ^c   Ryan, Mary ^d  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

American diabetes association; Angiotensin antagonists; Angiotesin converting enzyme inhibitors; Aspirin; Diabetes mellitus; Education; Interventions; Pharmaceutical services; Pharmacists; Physicians; Platelet aggregation inhibitors; Prescribing; Protocols; Rational therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DRUG USE; FAMILY MEDICINE; FEMALE; HOSPITAL PHARMACY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL;

EID: 77249118209     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp090009     Document Type: Article

References (17)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta: U.S. Department of Health and Human Services; 2007.
2. Centers for Disease Control and Prevention. National diabetes fact sheet; general information and national estimates on diabetes in the United States, 2005. Atlanta: U.S. Department of Health and Human Services; 2005.
3. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care. 2008; 31(suppl 1):S12-54.
4. UKPDS. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998; 317:703-13.
5. Adler AI, Stratton IM, Neil HA et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000; 321:412-9.
6. Hansson I, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998; 351:1755-62.
7. Colwell JA. Aspirin therapy in diabetes. Diabetes Care. 2003; 26(suppl 1):S87-8.
8. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care. 2009; 32(suppl 1):S13-61.
9. Dolovich L, Pottie K, Kaczorowski J et al. Integrating family medicine and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther. 2008; 83:913-7.
10. Andrus MR, Clark DB. Provision of pharmacotherapy services in a rural nurse practitioner clinic. Am J Health-Syst Pharm. 2007; 64:294-7.
11. Machado M, Bajcar J, Guzzo GC et al. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007; 41:1569-82.
12. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs, and patient outcomes. Cochrane Database Syst. Rev. 2000; 3:CD000336.
13. National Committee for Quality Assurance. The state of health care quality 2007. www.ncqa.org/Portals/0/Publications/Resource%20Library/SOHC-07.pdf (accessed 2008 Nov 3).
14. Klaus SL, Hamilton RA. Medicaid prescriber compliance with Joint National Committee VI hypertension treatment guidelines. Ann Pharmacother. 2002; 36:1505-11.
15. Jami P, Smith P, Moningi S et al. Compliance with Joint National Committee 7 guidelines in hypertension management at a teaching institution. Am J Med Qual. 2007; 22:251-8.
16. Haggerty SA, Cerulli J, Zeolla MM et al. Community pharmacy target intervention program to improve aspirin use in persons with diabetes. J Am Pharm Assoc. 2005; 45:17-22.
17. Faragon JJ, Waite NM, Hobson EH et al. Improving aspirin prophylaxis in a primary care diabetic population. Pharmacotherapy. 2003; 23:73-9.